FDA Approved: AFINITOR — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved the original application for Afinitor (everolimus) from Novartis, granting marketing authorization for its use in treating renal cell carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Afinitor (everolimus)

Snippet

ORIG AP for AFINITOR (EVEROLIMUS)